- funded by IMI-JU
- 01 March 2011 - 29 February 2016
- 11 EFPIA members
- 10 Academia and 6 SME's
- Total cost € 23,280,034
The Drug Disease Model Resources (DDMoRe) consortium has been created to improve the quality, efficiency and cost effectiveness of model-informed decisions in drug development and therapeutic use of marketed drugs.
The platform will deliver consistency of evidence that industry and health authorities can rely on in making decisions about development and approval of new medicines. It will also be a resource for academic research and improvement of therapy with existing drugs. Information from a wide array of sources can be integrated into models to describe and predict the behavior of complex disease/biological systems and drug actions.
DDMoRe’s products deliver an open source, integrated framework to enable Model Informed Drug Discovery & Development:
An open, publicly available, free-to-use model repository. Based on the developed standards Pharmacomtrics Markup Language and Modelling Description Language, the repository will enable sharing and re-use of models.
An integrated infrastructure to enable efficient exchange and integration of models across modelling languages, existing and new tools.
Education and training in DDMoRe’s products and their use in drug/disease Modelling and Simulation.